FDA Approval for AI-Designed Drugs Probably Isn’t That Far Away

May 18, 2026, 10:00 AM UTC

Trying to get medicine approved by the US Food and Drug Administration often feels like buying an expensive lottery ticket, with the uncertain prospect of a reward years away. It takes about a decade and more than $1 billion on average to take a drug through all the stages of clinical trials, and about 90% never get that far.

Part of the problem is the way researchers discover treatments. Until recently, scientists would come up with a hypothesis and run numerous tests to find a chemical capable of shutting down, say, a disease-causing protein. Then they’d run additional tests to ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.